These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 7021987)
1. [HLA and bone marrow transplantation (BMT) (author's transl)]. Goldmann SF Klin Padiatr; 1981 May; 193(3):266-71. PubMed ID: 7021987 [TBL] [Abstract][Full Text] [Related]
2. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959 [TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
4. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center]. van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation in the treatment of hematologic diseases. Yee GC; McGuire TR Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. Bacigalupo A; Hows J; Gordon-Smith EC; Gluckman E; Van Lint MT; Congiu M; James DC; Barrett AJ; Gmur J; De Planque MM Bone Marrow Transplant; 1988 Nov; 3(6):531-5. PubMed ID: 3063321 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428 [TBL] [Abstract][Full Text] [Related]
8. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation. Russell CA Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093 [TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors. Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692 [TBL] [Abstract][Full Text] [Related]
10. Use of HLA genotypically different donors in bone marrow transplantation. Dupont B; O'Reilly RJ; Pollack MS; Good RA Transplant Proc; 1979 Mar; 11(1):219-24. PubMed ID: 156423 [No Abstract] [Full Text] [Related]
14. [Indications, technique and risks in bone marrow transplantation in adulthood]. Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901 [TBL] [Abstract][Full Text] [Related]
15. Unrelated donor marrow transplantation for severe aplastic anaemia. Howard MR Transfus Sci; 1991; 12(3):123-34. PubMed ID: 10149542 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience. Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390 [TBL] [Abstract][Full Text] [Related]
17. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388 [TBL] [Abstract][Full Text] [Related]
18. [Bone marrow transplantation in leukemia and aplastic anemia]. Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience. Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957 [TBL] [Abstract][Full Text] [Related]
20. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation. Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]